Intestinal GPS: Bile and bicarbonate control cyclic di-GMP to provide Vibrio cholerae spatial cues within the small intestine

Gut Microbes

Volumn 5, Issue 6, 2014, Pages 775-780

  Koestler, Benjamin J ^a   Waters, Christopher M ^a  

^a Michigan State University   (United States)

Author keywords

Bicarbonate; Bile; Cyclic di GMP; GGDEF; HD GYP; Vibrio cholerae

Indexed keywords

BICARBONATE; CYCLIC DIGUANOSINE MONOPHOSPHATE; CYCLIC GMP DERIVATIVE; OXYGEN; PHOSPHODIESTERASE; UNCLASSIFIED DRUG; ZINC; BILE ACID; BIS(3',5')-CYCLIC DIGUANYLIC ACID; CYCLIC GMP; DIGUANYLATE CYCLASE; ESCHERICHIA COLI PROTEIN; LYASE;

ARTICLE; BACTERIAL VIRULENCE; BILE; BIOFILM; CELL MOTILITY; CHOLERA; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE; HOST PATHOGEN INTERACTION; HUMAN; INTRACELLULAR SIGNALING; MICROBIOME; NONHUMAN; PH; PSEUDOMONAS AERUGINOSA; RHODOPSEUDOMONAS PALUSTRIS; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMALL INTESTINE; SPATIAL CUE; TURNOVER TIME; VIBRIO CHOLERAE; ANALOGS AND DERIVATIVES; ANIMAL; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIOLOGY;

VIBRIO CHOLERAE;

ANIMALS; BICARBONATES; BILE ACIDS AND SALTS; CYCLIC GMP; ESCHERICHIA COLI PROTEINS; HUMANS; INTESTINE, SMALL; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORUS-OXYGEN LYASES; VIBRIO CHOLERAE;

EID: 84922068233     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/19490976.2014.985989     Document Type: Article

References (41)

1. Ross P, Weinhouse H, Aloni Y, Michaeli D, Weinbergerohana P, Mayer R, Braun S, de Vroom E, van der Marel GA, van Boom JH, et al. Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid. Nature 1987; 325:279-81; PMID:18990795; http://dx.doi.org/10.1038/325279a0
2. Seshasayee ASN, Fraser GM, Luscombe NM. Comparative genomics of cyclic-di-GMP signaling in bacteria: post-translational regulation and catalytic activity. Nucleic Acids Res 2010; 38:5970-81; PMID:20483912; http://dx.doi.org/10.1093/nar/gkq382
3. Romling U, Galperin MY, Gomelsky M. Cyclic di- GMP: the First 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev 2013; 77:1-52; PMID:23471616; http://dx.doi.org/10.1128/MMBR. 00043-12
4. Bernier SP, Ha DG, Khan W, Merritt JH, O'Toole GA. Modulation of Pseudomonas aeruginosa surfaceassociated group behaviors by individual amino acids through c-di-GMP signaling. Res Microbiol 2011; 162:680-8; PMID:21554951; http://dx.doi.org/ 10.1016/j.resmic.2011.04.014
5. Zähringer F, Lacanna E, Jenal U, Schirmer T, Boehm A. Structure and signaling mechanism of a zinc-sensory diguanylate cyclase. Structure 2013; 21:1149-57; PMID:23769666; 10.1016/j.str.2013.04.026
6. Tuckerman JR, Gonzalez G, Sousa EHS, Wan XH, Saito JA, Alam M, Gilles-Gonzalez MA. An oxygensensing diguanylate cyclase and phosphodiesterase couple for c-di-GMP control. Biochemistry 2009; 48:9764-74; PMID:19764732; http://dx.doi.org/ 10.1021/bi901409g
7. Agostoni M, Koestler BJ, Waters CM, Williams BL, Montgomery BL. Occurrence of cyclic di-GMP-modulating output domains in cyanobacteria: an illuminating perspective. MBio 2013; 4:pii: e00451-13; PMID:23943760; http://dx.doi.org/10.1128/mBio. 00451-13
8. Kanazawa T, Ren S, Maekawa M, Hasegawa K, Arisaka F, Hyodo M, Hayakawa Y, Ohta H, Masuda S. Biochemical and physiological characterization of a BLUF protein-EAL protein complex involved in blue lightdependent degradation of cyclic diguanylate in the purple bacterium Rhodopseudomonas palustris. Biochemistry 2010; 49:10647-55; PMID:21082778; http://dx. doi.org/10.1021/bi101448t
9. Huq A, Small EB, West PA, Huq MI, Rahman R, Colwell RR. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol 1983; 45:275-83; PMID:6337551
10. Tamplin ML, Gauzens AL, Huq A, Sack DA, Colwell RR. Attachment of Vibrio cholerae serogroup-O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol 1990; 56:1977-80; PMID:2383016
11. Halpern M, Broza YB, Mittler S, Arakawa E, Broza M. Chironomid egg masses as a natural reservoir of Vibrio cholerae non-O1 and non-O139 in freshwater habitats. Microb Ecol 2004; 47:341-9; PMID:14681736; http:// dx.doi.org/10.1007/s00248-003-2007-6
12. Tischler AD, Camilli A. Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation. Mol Microbiol 2004; 53:857-69; PMID:15255898; http:// dx.doi.org/10.1111/j.1365-2958.2004.04155.x
13. Srivastava D, Hsieh M-L, Khataokar A, Neiditch MB, Waters CM. Cyclic di-GMP inhibits Vibrio cholerae motility by repressing induction of transcription and inducing extracellular polysaccharide production. Mol Microbiol 2013; 90:1262-76; PMID:24134710; http:// dx.doi.org/10.1111/mmi.12432
14. Tischler AD, Camilli A. Cyclic diguanylate regulates Vibrio cholerae virulence gene expression. Infect Immun 2005; 73:5873-82; PMID:16113306; http:// dx.doi.org/10.1128/IAI.73.9.5873-5882.2005
15. Tamayo R, Schild S, Pratt JT, Camili A. Role of cyclic di-GMP during El tor biotype Vibrio cholerae infection: characterization of the in vivo-induced cyclic di- GMP phosphodiesterase CdpA. Infect Immun 2008; 76:1617-27; PMID:18227161; http://dx.doi.org/ 10.1128/IAI.01337-07
16. Koestler BJ, Waters CM. Bile acids and bicarbonate inversely regulate intracellular cyclic di-GMP in vibrio cholerae. Infect Immun 2014; 82:3002-14; PMID:24799624; http://dx.doi.org/10.1128/IAI. 01664-14
17. Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005; 29:625-51; PMID:16102595; http://dx.doi.org/ 10.1016/j.femsre.2004.09.003
18. Gómez Zavaglia A, Kociubinski G, Pérez P, Disalvo E, De Antoni G. Effect of bile on the lipid composition and surface properties of bifidobacteria. J Appl Microbiol 2002; 93:794-9; PMID:12392525; http:// dx.doi.org/10.1046/j.1365-2672.2002.01747.x
19. Provenzano D, Klose KE. Altered expression of the ToxR-regulated porins OmpU and OmpT diminishes Vibrio cholerae bile resistance, virulence factor expression, and intestinal colonization. Proc Natl Acad Sci U S A 2000; 97:10220-4; PMID:10944196; http://dx. doi.org/10.1073/pnas.170219997
20. Wibbenmeyer JA, Provenzano D, Landry CF, Klose KE, Delcour AH. Vibrio cholerae OmpU and OmpT porins are differentially affected by bile. Infect Immun 2002; 70:121-6; PMID:11748172; http://dx.doi.org/ 10.1128/IAI.70.1.121-126.2002
21. Mey AR, Craig SA, Payne SM. Effects of amino acid supplementation on porin expression and ToxR levels in vibrio cholerae. Infect Immun 2012; 80:518-28; PMID:22144480; http://dx.doi.org/10.1128/IAI. 05851-11
22. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47:241-59; PMID:16299351; http://dx.doi.org/ 10.1194/jlr.R500013-JLR200
23. Berr F, Kullak-Ublick GA, Paumgartner G, Munzing W, Hylemon PB. 7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology 1996; 111:1611-20; PMID:8942741; http://dx.doi. org/10.1016/S0016-5085(96)70024-0
24. Faruque SM, Biswas K, Udden SMN, Ahmad QS, Sack DA, Nair GB, Mekalanos JJ. Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment. ProcNatl Acad Sci U S A 2006; 103:6350-5; PMID:16601099; http://dx. doi.org/10.1073/pnas.0601277103
25. Prouty AM, Gunn JS. Salmonella enterica serovar typhimurium invasion is repressed in the presence of bile. Infect Immun 2000; 68:6763-9; PMID:11083793; http://dx. doi.org/10.1128/IAI.68.12.6763-6769.2000
26. Krukonis ES, DiRita VJ. From motility to virulence: sensing and responding to environmental signals in Vibrio cholerae. Curr Opin Microbiol 2003; 6:186-90; PMID:12732310; http://dx.doi.org/10.1016/S1369- 5274(03)00032-8
27. Abuaita BH, Withey JH. Bicarbonate induces Vibrio cholerae virulence gene expression by enhancing ToxT activity. Infect Immun 2009; 77:4111-20; PMID: 19564378; http://dx.doi.org/10.1128/IAI.00409-09
28. Hogan DL, Ainsworth MA, Isenberg JI. Gastroduodenal bicarbonate secretion. Aliment Pharm Therap 1994; 8:475-88; http://dx.doi.org/10.1111/j.1365- 2036.1994.tb00319.x
29. Seidler U, Sjöblom M. Gastroduodenal bicarbonate secretion. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. San Diego: Elsevier, 2012:1311-39.
30. Desmet I, Vanhoorde L, Woestyne MV, Christiaens H, Verstraete W. Significance of bile-salt hydrolytic activities of lactobacilli. J Appl Bacteriol 1995; 79:292-301; PMID:7592123; http://dx.doi.org/10.1111/j.1365- 2672.1995.tb03140.x
31. Cerda-Maira FA, Ringelberg CS, Taylor RK. The bile response repressor BreR regulates expression of the vibrio cholerae breAB Efflux system operon. J Bacteriol 2008; 190:7441-52; PMID:18776020; http://dx.doi. org/10.1128/JB.00584-08
32. Cerda-Maira FA, Kovacikova G, Jude BA, Skorupski K, Taylor RK. Characterization of BreR interaction with the bile response promoters breAB and breR in vibrio cholerae. J Bacteriol 2013; 195:307- 17; PMID:23144245; http://dx.doi.org/10.1128/ JB.02008-12
33. Yang MH, Liu Z, Hughes C, Stern AM, Wang H, Zhong Z, Kan B, Fenical W, Zhu J. Bile salt-induced intermolecular disulfide bond formation activates Vibrio cholerae virulence. Proc Natl Acad Sci U S A 2013; 110:2348-53; PMID:23341592; http://dx.doi.org/ 10.1073/pnas.1218039110
34. Hung DT, Mekalanos JJ. Bile acids induce cholera toxin expression in Vibrio cholerae in a ToxT-independent manner. Proc Natl Acad Sci U S A 2005; 102:3028-33; PMID:15699331; http://dx.doi.org/ 10.1073/pnas.0409559102
35. Provenzano D, Schuhmacher DA, Barker JL, Klose KE. The virulence regulatory protein ToxR mediates enhanced bile resistance in Vibrio cholerae and other pathogenic Vibrio species. Infect Immun 2000; 68:1491-7; PMID:10678965; http://dx.doi.org/ 10.1128/IAI.68.3.1491-1497.2000
36. Goss TJ, Morgan SJ, French EL, Krukonis ES. ToxR recognizes a direct repeat element in the toxT, ompU, ompT and ctxA promoters of Vibrio cholerae to regulate transcription. Infect Immun 2013; 81:884-95; PMID:23297386; http://dx.doi. org/10.1128/IAI.00889-12
37. Srivastava D, Harris RC, Waters CM. Integration of cyclic di-GMP and quorum sensing in the control of vpsT and aphA in Vibrio cholerae. J Bacteriol 2011; 193:6331-41; PMID:21926235; http://dx.doi.org/ 10.1128/JB.05167-11
38. Massie JP, Reynolds EL, Koestler BJ, Cong J-P, Agostoni M, Waters CM. Quantification of high-specificity cyclic diguanylate signaling. Proc Natl Acad Sci U S A 2012; 109:12746-51; PMID:22802636; http://dx.doi. org/10.1073/pnas.1115663109
39. Garner CD, Antonopoulos DA, Wagner B, Duhamel GE, Keresztes I, Ross DA, Young VB, Altier C. Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a salmonella enterica serovar typhimurium murine model of infection. Infect Immun 2009; 77:2691-702; PMID:19433544; http:// dx.doi.org/10.1128/IAI.01570-08
40. Okolicsanyi L, Lirussi F, Strazzabosco M, Jemmolo RM, Orlando R, Nassuato G, Muraca M, Crepaldi G. The effect of drugs on bile-flow and composition-an overview. Drugs 1986; 31:430-48; PMID:2872047; http://dx.doi. org/10.2165/00003495-198631050-00003
41. Yang YX, Metz DC. Safety of proton pump inhibitor exposure. Gastroenterology 2010; 139:1115-27; PMID:20727892; http://dx.doi.org/10.1053/j.gastro. 2010.08.023